Cited by 1,873Pain Mechanisms and TreatmentsPain Management and TreatmentPain Management and Opioid Use

The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Open access

Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T.·2010·European Journal of Neurology

DOI 10.1111/j.1468-1331.2010.02999.x

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND OBJECTIVES: This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005. METHODS: Studies were identified using the Cochrane Database and Medline. Trials were classified according to the aetiological condition. All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies. Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting. RESULTS: Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions. Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions). Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A). CONCLUSIONS: There are still too few large-scale comparative studies. For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2010.02999.x

Cites

236 of 236 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 retracted

Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub2 · Cited by 409
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 247
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
Retracted
Topical lidocaine for the treatment of postherpetic neuralgia
Khaliq, W., Alam, S., & Puri, N. K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004846.pub2 · Cited by 160
Retracted
Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub3 · Cited by 153
Retracted
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,362
Untitled work
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Self-citation
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126

Show all 236 references

Sorted by citations

Items 401–500 of 1,000

Health Care Resource Utilization and Medical Costs of Spinal Cord Injury With Neuropathic Pain in a Commercially Insured Population in the United States
Margolis, J. M., Juneau, P. L., Sadosky, A., Cappelleri, J. C., Bryce, T. N., & Nieshoff, E. C. (2014) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2014.07.416 · Cited by 40
Evidence-Based Guidelines on the Use of Opioids in Chronic Non-Cancer Pain—A Consensus Statement by the Pain Association of Singapore Task Force
Ho, K., Chua, N. H. L., George, J. M., Yeo, S. N., Main, N. B., Choo, C. Y., Tan, J. W., Tan, K. H., & Ng, B. Y. (2013) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v42n3p138 · Cited by 39
Efficacy and safety of pregabalin for treating painful diabetic peripheral neuropathy: a meta‐analysis
Zhang, S., Wu, Z., Zhang, L., Zhang, Z., Chen, R., Huang, Y., & Chen, H. (2014) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12420 · Cited by 39
GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain
Hahm, E.-T., Kim, Y., Lee, J., & Cho, Y. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-41 · Cited by 39
Clinical guidelines for type 1 diabetes mellitus with an emphasis on older adults: an Executive Summary
Sinclair, A. J., Dunning, T. L., Dhatariya, K., & an International Group of Experts (2019) · Diabetic Medicine · doi:10.1111/dme.14135 · Cited by 42
Current views on acute to chronic pain transition in post-traumatic patients
Radresa, O., Chauny, J., Lavigne, G. J., Piette, E., Paquet, J., & Daoust, R. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000188 · Cited by 39
Assay sensitivity and study features in neuropathic pain trials: An ACTTION meta-analysis
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., He, H., McDermott, M. P., Farrar, J. T., Katz, N. P., Lin, A. H., Rappaport, B. A., & Rowbotham, M. C. (2013) · Neurology · doi:10.1212/wnl.0b013e318297ee69 · Cited by 38
Telemonitoring in Chronic Pain Management Using Smartphone Apps: A Randomized Controlled Trial Comparing Usual Assessment against App-Based Monitoring with and without Clinical Alarms
Suso-Ribera, C., Castilla, D., Zaragozá, I., Mesas, Á., Server, A., Medel, J., & García-Palacios, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186568 · Cited by 38
“This consisted of the usual medical treatment for their pain at the pain unit according to the usual practice at the pain clinic and pain guidelines [51,52].”
BackgroundMethod
Evidence-based Guidance for the Management of Postherpetic Neuralgia in Primary Care
Harden, R. N., Kaye, A. D., Kintanar, T., & Argoff, C. E. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.07.2690 · Cited by 38
Antinociceptive activity of the new triple reuptake inhibitor NS 18283 in a mouse model of chemotherapy‐induced neuropathic pain
Hache, G., Guiard, B. P., Nguyen, T. H., Quesseveur, G., Gardier, A. M., Peters, D., Munro, G., & Coudoré, F. (2014) · European Journal of Pain · doi:10.1002/ejp.550 · Cited by 39
Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain
Cruccu, G., Nurmikko, T. J., Ernault, É., Riaz, F., McBride, W. T., & Haanpää, M. L. (2017) · European Journal of Pain · doi:10.1002/ejp.1155 · Cited by 38
“…efficacy and tolerability of the capsaicin 8% patch has been confirmed in PHN, painful human immunodeficiency virus (HIV)-associated neuropathies (Backonja et al., 2008; Simpson et al., 2008; Irving et al., 2011; Brown et al., 2013), and more recently in painful diabetic peripheral neuropathy…”
BackgroundSelf-citation
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis
Caruso, R., Ostuzzi, G., Turrini, G., Ballette, F., Recla, E., Dall'Olio, R., Croce, E., Casoni, B., Grassi, L. G., & Barbui, C. (2019) · Pain · doi:10.1097/j.pain.0000000000001622 · Cited by 38
“To the best of our knowledge, this is the first systematic review and meta-analysis specifically focusing on the effect of antidepressants on psychiatric symptoms and quality of life in people suffering from neuropathic pain, which is largely overlooked by current scientific literature and clinical guidelines.(3,9,21,…”
Background
Lavandula angustifolia essential oil inhalation reduces mechanical hyperalgesia in a model of inflammatory and neuropathic pain: The involvement of opioid and cannabinoid receptors
Donatello, N. N., Emer, A. A., Salm, D. C., Lüdtke, D. D., Bordignon, S. A. S. R., Ferreira, J. K., Salgado, A. S. I., Venzke, D., Bretanha, L. C., Micke, G. A., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577145 · Cited by 44
Gabapentin alleviates affective pain after traumatic nerve injury
Griggs, R. B., Bardo, M. T., & Taylor, B. K. (2015) · Neuroreport · doi:10.1097/wnr.0000000000000382 · Cited by 38
Immersive interactive virtual walking reduces neuropathic pain in spinal cord injury: findings from a preliminary investigation of feasibility and clinical efficacy
Trost, Z., Anam, M., Seward, J., Shum, C., Rumble, D., Sturgeon, J., Mark, V., Chen, Y., Mitchell, L., Cowan, R., et al. (2022) · Pain · doi:10.1097/j.pain.0000000000002348 · Cited by 37
Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain
Zhu, C., Lan, X., Wei, Z., Yu, J., & Zhang, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.020 · Cited by 39
“The ﬁrst-line drugs for managing neuropathic pain are anti-convulsants ( e.g. , gabapentin and pregabalin), tricyclic antide-pressants (TCAs) ( e.g. , amitriptyline), and serotonin-norepinephrine reuptake inhibitors (SNRIs) ( e.g. , duloxetine and venlafaxine) 6 e 9 .”
Background
Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
Misawa, S., Denda, T., Kodama, S., Suzuki, T., Naito, Y., Kogawa, T., Takada, M., Suichi, T., Shiosakai, K., Kuwabara, S., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11560-4 · Cited by 37
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
Brouwer, B. A., de Greef, B. T. A., Hoeijmakers, J. G. J., Geerts, M., van Kleef, M., Merkies, I. S. J., & Faber, C. G. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0283-8 · Cited by 37
“Gabapentin and pregabalin are considered first-line treatment for neuropathic pain [12, 14, 15].”
BackgroundResultInfluential
Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain
Urtikova, N. A., Berson, N., Steenwinckel, J. V., Doly, S., Truchetto, J., Maroteaux, L., Pohl, M., & Conrath, M. (2012) · Pain · doi:10.1016/j.pain.2012.03.024 · Cited by 37
Nontricyclic antidepressant analgesics and pain: Are serotonin norepinephrine reuptake inhibitors (SNRIs) any better?
Watson, P. N. C., Gilron, I., Sawynok, J., & Lynch, M. E. (2011) · Pain · doi:10.1016/j.pain.2011.05.032 · Cited by 37
The antiallodynic action of nortriptyline and terbutaline is mediated by β2 adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy
Choucair‐Jaafar, N., Salvat, É., Freund‐Mercier, M. J., & Barrot, M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.12.016 · Cited by 37
Neuropathic Pain and Pharmacological Treatment
Jongen, J. L. M., Hans, G. H., Benzon, H. T., Huygen, F. J. P. M., & Hartrick, C. T. (2013) · Pain Practice · doi:10.1111/papr.12085 · Cited by 37
Neuropathic pain: a pathway for care developed by the British Pain Society
Smith, B. H., Lee, J., Price, C. M., & Baranowski, A. P. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet206 · Cited by 37
Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database
Asomaning, K., Abramsky, S., Liu, Q., Zhou, X., Sobel, R. E., & Watt, S. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12791 · Cited by 37
Adult Complex Regional Pain Syndrome Type I: A Narrative Review
Bussa, M., Mascaro, A., Cuffaro, L., & Rinaldi, S. (2016) · PM&R · doi:10.1016/j.pmrj.2016.11.006 · Cited by 37
“Opioids Strong opioid analgesics and tramadol are recommended for neuropathic pain as a second-line treatment [196-198], but there is insufficient evidence of the effectiveness of oral opioids in patients with CRPS I [5,171].”
Background
Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain
Zuena, A. R., Maftei, D., Alemà, G., Moro, F. D., Lattanzi, R., Casolini, P., & Nicoletti, F. (2018) · Molecular Pain · doi:10.1177/1744806918808987 · Cited by 37
“In contrast, antidepressants that inhibit both serotonin and noradrenaline reuptake, such as duloxetine, venlafaxine, amitriptyline, are gold standard drugs in the treatment of neuropathic pain.(12) Using an established mouse model of neuropathic pain, we have shown here for the first time that vortioxetine displays a…”
Background
Paroxysmal Symptoms in Multiple Sclerosis—A Review of the Literature
Freiha, J., Riachi, N. J., Chalah, M. A., Zoghaib, R., Ayache, S. S., & Ahdab, R. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103100 · Cited by 37
“, carbamazepine and oxcarbazepine [70].”
Background
Pain Characteristics and Biomarkers in Treatment Approaches for Osteoarthritis Pain
Fayet, M., & Hagen, M. (2020) · Pain Management · doi:10.2217/pmt-2020-0055 · Cited by 39
Prevalence and Characteristics of Neuropathic Pain in Patients With Spinal Cord Injury Referred to a Rehabilitation Center
Kim, H. Y., Lee, H.-J., Kim, T.-L., Kim, E.-Y., Ham, D., Lee, J., Kim, T., Shin, J. W., Son, M., Sung, J. H., et al. (2020) · Annals of Rehabilitation Medicine · doi:10.5535/arm.20081 · Cited by 38
“Our patient population was primarily being treated for SCI-related NP with anti-epileptic medication, TCAs, tramadol, and opioids as first- or second-line medication [36].”
Background
Oral administration of the p38α MAPK inhibitor, UR13870, inhibits affective pain behavior after spinal cord injury
Galán-Arriero, I., Ávila-Martín, G., Ferrer-Donato, Á., Gómez‐Soriano, J., Bravo-Esteban, E., & Taylor, J. (2014) · Pain · doi:10.1016/j.pain.2014.08.030 · Cited by 38
Nonopioid Medications for Pain
Tauben, D. J. (2015) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2015.01.005 · Cited by 37
Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones
Cao, X., Chen, Y., Zhang, Y., Lan, Y., Zhang, J., Xu, X., Qiu, Y., Zhao, S., Liu, X., Liu, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01416 · Cited by 37
Red Pepper
Singletary, K. W. (2011) · Nutrition Today · doi:10.1097/nt.0b013e3182076ff2 · Cited by 37
Overlaps in pharmacology for the treatment of chronic pain and mental health disorders
Sutherland, A. M., Nicholls, J., Bao, J., & Clarke, H. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.017 · Cited by 36
“The anticonvulsants gabapentin and pregabalin are considered first line agents for neuropathic pain (Attal et al., 2010; Finnerup et al., 2015; Moulin et al., 2014).”
Influential
Pharmacological versus microvascular decompression approaches for the treatment of trigeminal neuralgia: clinical outcomes and direct costs
Almeida, A., Lemos, Alegria, C., Oliveira, Oliveira, J., & Machado (2011) · Journal of Pain Research · doi:10.2147/jpr.s20555 · Cited by 36
Treatment Options in Paraneoplastic Disorders of the Peripheral Nervous System
Antoine, J.-C. G., & Camdessanché, J. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-012-0210-9 · Cited by 36
Management of neuropathic pain after knee surgery
Vergne‐Salle, P. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.06.001 · Cited by 36
Classification and Characteristics of Pain Associated with Parkinson’s Disease
Blood, M. R. Y., Ferro, M. M., Munhoz, R. P., Teive, H. A. G., & Camargo, C. H. F. (2016) · Parkinson s Disease · doi:10.1155/2016/6067132 · Cited by 36
“The firstline drug treatments for neuropathic pain are amitriptyline, duloxetine, and pregabalin [62].”
Background
Comparison of methodological quality rating of systematic reviews on neuropathic pain using AMSTAR and R-AMSTAR
Došenović, S., Kadić, A. J., Vučić, K., Markovina, N., Pieper, D., & Puljak, L. (2018) · BMC Medical Research Methodology · doi:10.1186/s12874-018-0493-y · Cited by 34
Pitfals in recognition and management of trigeminal neuralgia
Antonaci, F., Arceri, S., Rakuša, M., Mitsikostas, D. D., Milanov, I. G., Todorov, V. V., Ramusino, M. C., & Costa, A. C. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01149-8 · Cited by 37
Neuropathic pain following spinal cord injury: what we know about mechanisms, assessment and management.
D’Angelo, R., Morreale, A., Donadio, V. A., Boriani, S., Maraldi, N. M., Plazzi, G., & Liguori, R. (2013) · PubMed · Cited by 36
The Efficacy of Gabapentin in Patients with Central Post-stroke Pain.
Hesami, O., Gharagozli, K., Beladimoghadam, N., Assarzadegan, F., Mansouri, B., & Sistanizad, M. (2015) · PubMed Central · Cited by 36
Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
Sadosky, A., Taylor‐Stokes, G., Pike, J., Sadosky, A., & Chandran, A. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s27455 · Cited by 35
Approach to Peripheral Neuropathy for the Primary Care Clinician
Doughty, C. T., & Sadjadi, R. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.042 · Cited by 36
61. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
Stefano, G. D., Biasiotta, A., Cesa, S. L., Leone, C. M., Pepe, A., Piroso, S., Truini, A., & Cruccu, G. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.10.080 · Cited by 35
Self-citation
Anti-epileptic Drugs
Howard, P. D., Twycross, R., Shuster, J. L., Mihalyo, M., Rémi, J., & Wilcock, A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.10.007 · Cited by 35
COL6A5variants in familial neuropathic chronic itch
Boneschi, F. M., Colombi, M., Castori, M., Devigili, G., Eleopra, R., Malik, R. A., Ritelli, M., Zoppi, N., Dordoni, C., Sorosina, M., et al. (2016) · Brain · doi:10.1093/brain/aww343 · Cited by 36
“Gabapentinoids, one of the first-line treatments for neuropathic pain (Attal et al., 2010), bind to the Figure 4 Skin biopsy sections in itch patients carrying COL5A6 variants.”
Background
Antinociceptive Effects of Isosakuranetin in a Rat Model of Peripheral Neuropathy
Jia, S., Zhang, Y., & Yu, J. (2017) · Pharmacology · doi:10.1159/000478986 · Cited by 35
Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015
Baftiu, A., Feet, S. A., Larsson, P. G., Burns, M. L., Henning, O. J., Sætre, E., Molden, E., Granås, A. G., Johannessen, S. I., & Landmark, C. J. (2017) · Epilepsy Research · doi:10.1016/j.eplepsyres.2017.11.001 · Cited by 35
0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial
Kulkantrakorn, K., Chomjit, A., Sithinamsuwan, P., Tharavanij, T., Suwankanoknark, J., & Napunnaphat, P. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.11.036 · Cited by 35
The Role of Fat Grafting in Alleviating Neuropathic Pain: A Critical Review of the Literature
Bonetti, M. A., Egro, F. M., Persichetti, P., Coleman, S. R., & Rubin, J. P. (2019) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000002216 · Cited by 35
Rh(III)-Catalyzed C–H Amidation of Arenes with N-Methoxyamide as an Amidating Reagent
Ju, G., Li, G., Qian, G., Zhang, J., & Zhao, Y. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02625 · Cited by 35
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Marchettini, P., Wilhelm, S., Petto, H., Tesfaye, S. H., Tölle, T. R., Bouhassira, D., Freynhagen, R., Cruccu, G., Lledó, A., Choy, E., et al. (2015) · European Journal of Pain · doi:10.1002/ejp.763 · Cited by 38
“Pharmacotherapies commonly used in DPNP include tricyclic antidepressants, duloxetine, venlafaxine, pregabalin and gabapentin, and opioids (Attal et al., 2010; Kalso et al., 2013; Ney et al., 2013; Vinik and Casellini, 2013).”
BackgroundSelf-citation
Pharmacologic Therapies in Musculoskeletal Conditions
Loveless, M. S., & Fry, A. L. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.03.015 · Cited by 35
Effectiveness of Duloxetine Compared With Pregabalin and Gabapentin in Diabetic Peripheral Neuropathic Pain
Happich, M., Schneider, E. M., Boess, F., Wilhelm, S., Schacht, A., Birklein, F., & Ziegler, D. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000057 · Cited by 34
Symptomatic cranial neuralgias in multiple sclerosis: Clinical features and treatment
Santi, L. D., & Annunziata, P. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.10.044 · Cited by 34
Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with post-herpetic neuralgia
Webster, L. R., Nunez, M., Tark, M. D., Dunteman, E. D., Lu, B., Tobias, J. K., & Vanhove, G. F. (2011) · BMC Anesthesiology · doi:10.1186/1471-2253-11-25 · Cited by 34
Agomelatine: a new opportunity to reduce neuropathic pain—preclinical evidence
Chenaf, C., Chapuy, E., Libert, F., Marchand, F., Courteix, C., Bertrand, M., Gabriel, C., Mocaër, E., Eschalier, A., & Authier, N. (2016) · Pain · doi:10.1097/j.pain.0000000000000738 · Cited by 34
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain
Jiang, H., Ke, B., Liu, J., Ma, G., Hai, K., Gong, D., Yang, Z., & Zhou, C. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003563 · Cited by 35
Mirogabalin and emerging therapies for diabetic neuropathy
Javed, S., Alam, U., & Malik, R. A. (2018) · Journal of Pain Research · doi:10.2147/jpr.s145999 · Cited by 36
Effect of Postoperative Administration of Pregabalin for Post-thoracotomy Pain: A Randomized Study
Yoshimura, N., Iida, H., Takenaka, M., Tanabe, K., Yamaguchi, S., Kitoh, K., Shirahashi, K., & Iwata, H. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.05.117 · Cited by 34
Intravenous lidocaine in the management of chronic peripheral neuropathic pain: a randomized-controlled trial
Moulin, D. E., Morley-Forster, P., Pirani, Z., Rohfritsch, C., & Stitt, L. (2019) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-019-01395-8 · Cited by 34
Anxiolytic effects of the novel α2δ ligand mirogabalin in a rat model of chronic constriction injury, an experimental model of neuropathic pain
Murasawa, H., Kobayashi, H., Saeki, K., & Kitano, Y. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05356-3 · Cited by 34
Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial
Satoh, J., Yagihashi, S., Baba, M., Suzuki, M., Arakawa, A., & Yoshiyama, T. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00122.x · Cited by 34
Screening for Neuropathic Characteristics in Failed Back Surgery Syndromes: Challenges for Guiding Treatment
Markman, J. D., Kress, B. T., Frazer, M. E., Hanson, R., Kogan, V., & Huang, J. H. (2014) · Pain Medicine · doi:10.1111/pme.12612 · Cited by 34
Factors associated with chronic pain in patients with bipolar depression: a cross-sectional study
Failde, I., Dueñas, M., Agüera-Ortíz, L., Cervilla, J. A., González-Pinto, A. M., & Micó, J. A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-112 · Cited by 33
Duloxetine in Painful Diabetic Neuropathy
Hossain, S. M., Hussain, S. M., & Ekram, A. S. (2015) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000343 · Cited by 33
Longitudinal pattern of pain medication utilization in peripheral neuropathy patients
Callaghan, B. C., Reynolds, E. L., Banerjee, M., Kerber, K. A., Skolarus, L. E., & Burke, J. F. (2018) · Pain · doi:10.1097/j.pain.0000000000001439 · Cited by 34
“Given that the best evidence supports the use of nonopioids, optimal treatment algorithms may require that a patient fail at least 3 guideline-recommended medications, one in each of the 3 effective classes (SNRIs, TCAs, and gabapentinoids) before trying alternative therapies.(1,2,9,12,20) Perhaps even better would be…”
Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia
Bugden, S., Friesen, K. J., Falk, J., Alessi‐Severini, S., & Chateau, D. (2016) · Journal of Pain Research · doi:10.2147/jpr.s107944 · Cited by 33
“These include the risk of dependency, the development of tolerance, and the potential for abuse, and are part of the rationale for listing opioids as second-line PHN treatment options.(15,27) However, opioids were used frequently to treat HZ–PHN episodes (Figure 2).”
Treatment of painful diabetic peripheral neuropathy
Rosenberg, C. J., & Watson, J. C. (2015) · Prosthetics and Orthotics International · doi:10.1177/0309364614542266 · Cited by 33
Inhaled hydrogen sulfide prevents neuropathic pain after peripheral nerve injury in mice
Kida, K., Marutani, E., Nguyen, R. K., & Ichinose, F. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.11.014 · Cited by 33
Antinociceptive effects of oxymatrine from Sophora flavescens, through regulation of NR2B-containing NMDA receptor-ERK/CREB signaling in a mice model of neuropathic pain
Wang, H., Li, Y., Linglu, D., Xu, Y., Jin, S., Du, J., Ma, L., Li, J., Zhou, R., He, X., et al. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.04.012 · Cited by 33
Pain in malignant hematology
Niscola, P., Tendas, A., Scaramucci, L., Giovaninni, M., Cupelli, L., Sanctis, V. D., Brunetti, G. A., Bondanini, F., Palumbo, R., Lamanda, M., et al. (2011) · Expert Review of Hematology · doi:10.1586/ehm.10.79 · Cited by 33
Randomized, Double-Blind, Crossover Trial of Amitriptyline for Analgesia in Painful HIV-Associated Sensory Neuropathy
Dinat, N., Marinda, E. T., Moch, S. L., Rice, A. S. C., & Kamerman, P. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126297 · Cited by 33
Management of Peripheral Neuropathy Induced by Chemotherapy
Fradkin, M., Batash, R., Elmaleh, S., Debi, R., Schaffer, P. M., Schaffer, M., & Asna, N. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190107163756 · Cited by 33
New developments in the treatment algorithm for peripheral neuropathic pain.
de Leon-Casasola, O. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01160.x · Cited by 32
Suicidality associated with antiepileptic drugs: Implications for the treatment of neuropathic pain and fibromyalgia
Pereira, A. C., Gitlin, M. J., Gross, R. A., Posner, K., & Dworkin, R. H. (2013) · Pain · doi:10.1016/j.pain.2012.12.024 · Cited by 32
Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study
Hermanns, K., JUNKER, U., & Nolte, T. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.648615 · Cited by 32
Inhibition of the potassium channel K Ca 3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury
Staal, R. G. W., Khayrullina, T., Zhang, H., Davis, S., Fallon, S. M., Cajina, M., Nattini, M. E., Hu, A., Hua, Z., Poda, S. B., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.031 · Cited by 33
Are Opioids Effective in Relieving Neuropathic Pain?
Schembri, E. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0009-4 · Cited by 37
3-(4-Chlorophenylselanyl)-1-methyl-1H-indole promotes recovery of neuropathic pain and depressive-like behavior induced by partial constriction of the sciatic nerve in mice
Birmann, P. T., Sousa, F. S. S., Domingues, M., Brüning, C. A., Vieira, B. M., Lenardao, E. J., & Savegnago, L. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.04.014 · Cited by 32
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia
Gudin, J. A., Fudin, J., Wang, E., Haylon, T., Patel, K., & Goss, T. F. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19093 · Cited by 32
Wallenberg’s syndrome and symptomatic trigeminal neuralgia
Ordás, C., Cuadrado, M. L., Simal, P., Barahona‐Hernando, R., Casas, J., Matías‐Guiu, J. A., & Porta-Etessam, J. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0305-9 · Cited by 31
Effects of Carbamazepine/Oxycodone Coadministration in the Treatment of Trigeminal Neuralgia
Siniscalchi, A., Gallelli, L., Avenoso, T., Squillace, A., & Sarro, G. D. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q013 · Cited by 32
Noradrenaline increases pain facilitation from the brain during inflammatory pain
Martins, I., de Vries, M. G., Teixeira-Pinto, A. M., Fadel, J. R., Wilson, S. P., Westerink, B. H. C., & Tavares, I. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.007 · Cited by 32
Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients
Watkins, C. C., Pieper, A. A., & Treisman, G. J. (2011) · Drug Safety · doi:10.2165/11592070-000000000-00000 · Cited by 33
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
Notartomaso, S., Mascio, G., Bernabucci, M., Zappulla, C., Scarselli, P., Cannella, M., Imbriglio, T., Gradini, R., Battaglia, G., Bruno, V., et al. (2017) · Molecular Pain · doi:10.1177/1744806917697009 · Cited by 32
“Tramadol is a m opioid receptor agonist that can also inhibit serotonin and noradrenaline uptake and is widely used in the treatment of different types of pain including neuropathic pain.(32) Ceftriaxone is a b-lactam antibiotic that induces the expression of the glial glutamate transporter, GLT-1, thereby causing ana…”
BackgroundMethod
Pain‐relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
Hansson, P. T., Jensen, T. S., Kvarstein, G., & Strømberg, M. (2018) · European Journal of Pain · doi:10.1002/ejp.1180 · Cited by 32
“These treatments, however, are limited by central nervous system adverse effects, such as somnolence and dizziness, and for the latter, the potential for drug dependence (Attal et al., 2010; Finnerup et al., 2010, 2015; Tesfaye et al., 2011; Smith et al., 2012; Gahr et al., 2013).”
BackgroundSelf-citation
Comparing the DN4 tool with the IASP grading system for chronic neuropathic pain screening after breast tumor resection with and without paravertebral blocks
Abdallah, F. W., Morgan, P. J., Cil, T. D., Escallon, J. M., Semple, J. L., & Chan, V. W. S. (2015) · Pain · doi:10.1097/j.pain.0000000000000108 · Cited by 31
The nitroxyl donor, Angeli’s salt, reduces chronic constriction injury-induced neuropathic pain
Longhi-Balbinot, D. T., Rossaneis, A. C., Pinho-Ribeiro, F. A., Bertozzi, M. M., Cunha, F. Q., Alves-Filho, J. C., Cunha, T. M., Peron, J. P. S., Miranda, K. M., Casagrande, R., et al. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.06.009 · Cited by 33
“Notably, chronic pain represents a therapeutic challenge for clinicians due to severity, frequency, limited effective treatment and several side effects [1,2,15,16].”
BackgroundMethod
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
Dermer, H., Lent-Schochet, D., Theotoka, D., Paba, C., Cheema, A. A., Kim, R. S., & Galor, A. (2020) · Drugs · doi:10.1007/s40265-020-01282-3 · Cited by 31
Diabetic neuropathy in children and youth: New and emerging risk factors
Akıncı, G., Savelieff, M. G., Gallagher, G., Callaghan, B. C., & Feldman, E. L. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13153 · Cited by 30
Small Fiber Neuropathy
Strand, N. H., Wie, C. S., Peck, J., Maita, M., Singh, N., Dumbroff, J., Francio, V. T., Murphy, M. T., Chang, K., Dickerson, D. M., et al. (2022) · Current Pain and Headache Reports · doi:10.1007/s11916-022-01044-8 · Cited by 32
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia
Sabatowski, R., Hans, G. H., Tacken, I., Kapanadze, S., Buchheister, B., & Baron, R. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.707977 · Cited by 31
Self-citation
Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
Gonen, T., & Amital, H. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10389 · Cited by 34
Assessing and treating primary headaches and cranio-facial pain in patients undergoing rehabilitation for neurological diseases
Tassorelli, C., Tramontano, M., Berlangieri, M., Schweiger, V., D’Ippolito, M., Palmerini, V., Bonazza, S., Rosa, R., Cerbo, R., & Buzzi, M. G. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0809-z · Cited by 31
Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature
Wang, L., Verschuuren, E. A. M., van Leer‐Buter, C., Bakker, S. J. L., de Joode, A. A. E., Westra, J., & Bos, N. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01632 · Cited by 30
“According to the guidelines (2010) issued by the European Federation of Neurological Societies, tricyclic antidepressants (TCAs), antiepileptics (gabapentin/pregabalin), and topical lidocaine plaster (5%) are recommended as first-line treatment in PHN (57).”
The role of the endogenous neurotransmitters associated with neuropathic pain and in the opioid crisis: The innate pain-relieving system
Bán, E.-G., Brassai, A., & Vizi, E. S. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.12.001 · Cited by 30
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Adamo, D., Calabria, E., Coppola, N., Pecoraro, G., & Mignogna, M. D. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211034320 · Cited by 33
Perioperative management of patients taking treatment for chronic pain
Farrell, C., & McConaghy, P. (2012) · BMJ · doi:10.1136/bmj.e4148 · Cited by 30

Authors: Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T.
Affiliations: Inserm (FR)
Sapienza University of Rome (IT)
University Hospital Schleswig-Holstein (DE)
Helsinki University Hospital (FI)
Karolinska University Hospital (SE)
Aarhus University Hospital (DK)
University of Liverpool (GB)
Corresponding author: Attal, N.
ORCID: Attal, N.
Cruccu, G.
Baron, R.
Haanpää, M.
Hansson, P.
Jensen, T. S.
Nurmikko, T.
Venue: European Journal of Neurology
Publisher: Wiley
Published: 2010-04-07
Volume: 17
Issue: 9
Pages: 1113
ISSN: 1351-5101 (ISSN-L)
1468-1331
DOI: 10.1111/j.1468-1331.2010.02999.x
OpenAlex: W2128412489
Cited by: 1,873
References: 236
Citations by year: 2026: 39 · 2025: 59 · 2024: 85 · 2023: 81 · 2022: 91 · 2021: 128 · 2020: 134 · 2019: 112 · 2018: 102 · 2017: 151 · 2016: 136 · 2015: 152 · 2014: 185 · 2013: 185 · 2012: 121
FWCI: 89.44
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: European Journal of Neurology (publishedVersion)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: neuropathic pain, pharmacotherapy, diabetic polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, chronic radiculopathy, HIV neuropathy, tricyclic antidepressants, pregabalin, gabapentin, tramadol, opioids, duloxetine, venlafaxine, topical lidocaine, capsaicin patch, combination therapy, treatment efficacy
MeSH terms: Gabapentin, Amines, Analgesia, Analgesics, Analgesics, Opioid, Antidepressive Agents, Tricyclic, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Europe, gamma-Aminobutyric Acid, Humans, Neuralgia, Peripheral Nervous System Diseases, Randomized Controlled Trials as Topic, Treatment Outcome, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks